144 results
Page 2 of 8
8-K/A
EX-10.1
aihc416rjz9zgklg8wg
28 Oct 22
Other Events
4:05pm
8-K
EX-10.4
sgc3zlz7
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
xijlxvc7
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.5
wt1kvgteg4qn6z
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-4.2
8d3lxujybtv
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-4.3
dv557gu
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
miij8oe4k1ot7w
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
5p0soeoa4d y6gms
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
EX-10.1
zaeb0hfxmi0dyl
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
3cj24otpi iuubzdkjlk
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-10.2
l7afntenk b83
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-10.3
a5muevgy2d zkrh6s4
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-10.1
aqzc6 8iiy65k
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
8-K
EX-10.2
u0o5qpspn 9q
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
424B5
it4zt9
31 Mar 22
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
t4011gm3u za5vg
22 Mar 22
Aravive Appoints Scott Dove, Ph.D., as Chief Operating Officer
4:06pm